<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03073720</url>
  </required_header>
  <id_info>
    <org_study_id>1606-ABU-048-HF</org_study_id>
    <nct_id>NCT03073720</nct_id>
  </id_info>
  <brief_title>Follicular Fluid, Bioavailable Vitamin D and Embryo Quality Markers</brief_title>
  <official_title>Correlation Between Follicular Fluid Levels of Bioavailable Vitamin D and Embryo Quality Markers: Euploid Status, Morphokinetics and Mitochondrial DNA Content Among UAE Women Undergoing an IVF Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Middle East Fertility Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Middle East Fertility Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the correlation between bioavailable Vitamin D values and euploid status of the
      embryos in larger size follicles from UAE women undergoing in vitro fertilization procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the possible correlation between bioavailable vitamin D values in follicular fluid
      and embryo quality markers.

      To correlate bioavailable Vitamin D values in follicular fluid from large size follicles with
      embryo euploid status as our main objective. Secondly, looking at morphokinetics and
      mitochondrial content of these embryos.

      Taking into account that most of UAE patients have deficiency or insufficiency of Vitamin D,
      if there is a correlation found we will understand better the underlying mechanism by which
      bioavailable Vitamin D levels may be affecting embryo quality, therefore IVF outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 26, 2017</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D values in follicular fluid and embryo quality markers among UAE women undergoing an IVF cycle</measure>
    <time_frame>6-10 months</time_frame>
    <description>A correlation between vitamin D levels and embryo development patterns</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      follicular fluid,serum sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        UAE patients with infertility (primary or secondary) and indication for IVF/ICSI treatment
        with PGS
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women´s Age &gt;18 - ≤43 years.

          -  BMI 19-30

          -  Male partner will produce fresh sperm sample on the same day of the egg collection
             procedure.

          -  Women with more than 10 follicles at the time of the trigger

          -  At the time of egg retrieval, at least three follicles between 14-&lt;17 mm and three
             follicles ≥17 mm.

          -  Women ≤35 years old stimulation with rFSH antagonist

          -  Women ≥36 years old stimulation with highly-purified human menopausal gonadotropins
             (hpHMG) specifically for the additional LH.

          -  Middle East population

        Exclusion Criteria:

          -  Polycystic ovarian syndrome (according to the Rotterdam Criteria).

          -  Patients at risk of OHSS, according to the criteria previously described by
             Papanikolau et al. (23).

          -  History of endometriosis, classified according to the American Fertility Society (AFS)
             as stage 3 or more.

          -  Severe male factor definition (&lt;2 million of sperm per ml of ejaculate)

          -  Recurrent miscarriage (3 miscarriages)

          -  Smokers

          -  History of chemotherapy or radiotherapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Human Fatemi, Medical D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Middle East Fertility Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana Arnaz, Embryologist</last_name>
    <phone>+971563703889</phone>
    <email>ana.arnaz@ivirma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elissavet Kamperi, Study Nurse</last_name>
    <email>elissavet.kamperi@ivirma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVI Middle East Fertilty Clinic</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>IVI Middle East Fertility clinic</last_name>
      <phone>+97126528000</phone>
      <email>info@ivirma.com</email>
    </contact>
    <investigator>
      <last_name>Human Fatemi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <reference>
    <citation>Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81. Review.</citation>
    <PMID>17634462</PMID>
  </reference>
  <reference>
    <citation>Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol. 2013 Jun 1;5(3):331-47. doi: 10.4161/derm.26738. Epub 2013 Nov 5. Review.</citation>
    <PMID>24516687</PMID>
  </reference>
  <reference>
    <citation>Anagnostis P, Karras S, Goulis DG. Vitamin D in human reproduction: a narrative review. Int J Clin Pract. 2013 Mar;67(3):225-35. doi: 10.1111/ijcp.12031. Epub 2013 Jan 7. Review.</citation>
    <PMID>23294318</PMID>
  </reference>
  <reference>
    <citation>Coney P, Demers LM, Dodson WC, Kunselman AR, Ladson G, Legro RS. Determination of vitamin D in relation to body mass index and race in a defined population of black and white women. Int J Gynaecol Obstet. 2012 Oct;119(1):21-5. doi: 10.1016/j.ijgo.2012.05.024. Epub 2012 Jul 18.</citation>
    <PMID>22818533</PMID>
  </reference>
  <reference>
    <citation>Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014 May;99(5):E886-90. doi: 10.1210/jc.2013-4374. Epub 2014 Feb 27.</citation>
    <PMID>24606102</PMID>
  </reference>
  <reference>
    <citation>Hussain AN, Alkhenizan AH, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia. Arch Osteoporos. 2014;9:190. doi: 10.1007/s11657-014-0190-3. Epub 2014 Sep 12.</citation>
    <PMID>25213798</PMID>
  </reference>
  <reference>
    <citation>Farzadi L, Khayatzadeh Bidgoli H, Ghojazadeh M, Bahrami Z, Fattahi A, Latifi Z, Shahnazi V, Nouri M. Correlation between follicular fluid 25-OH vitamin D and assisted reproductive outcomes. Iran J Reprod Med. 2015 Jun;13(6):361-6.</citation>
    <PMID>26330851</PMID>
  </reference>
  <reference>
    <citation>Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, Seto-Young D. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res. 2010 Sep;42(10):754-7. doi: 10.1055/s-0030-1262837. Epub 2010 Aug 13.</citation>
    <PMID>20711952</PMID>
  </reference>
  <reference>
    <citation>Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon C, Pal L. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril. 2010 Sep;94(4):1314-9. doi: 10.1016/j.fertnstert.2009.05.019. Epub 2009 Jul 8.</citation>
    <PMID>19589516</PMID>
  </reference>
  <reference>
    <citation>Anifandis GM, Dafopoulos K, Messini CI, Chalvatzas N, Liakos N, Pournaras S, Messinis IE. Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome. Reprod Biol Endocrinol. 2010 Jul 28;8:91. doi: 10.1186/1477-7827-8-91.</citation>
    <PMID>20667111</PMID>
  </reference>
  <reference>
    <citation>Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod. 2012 Nov;27(11):3321-7. doi: 10.1093/humrep/des280. Epub 2012 Aug 21.</citation>
    <PMID>22914766</PMID>
  </reference>
  <reference>
    <citation>Franasiak JM, Molinaro TA, Dubell EK, Scott KL, Ruiz AR, Forman EJ, Werner MD, Hong KH, Scott RT Jr. Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts. Am J Obstet Gynecol. 2015 Mar;212(3):315.e1-6. doi: 10.1016/j.ajog.2014.09.029. Epub 2014 Oct 11.</citation>
    <PMID>25265402</PMID>
  </reference>
  <reference>
    <citation>Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986 Oct;63(4):954-9.</citation>
    <PMID>3745408</PMID>
  </reference>
  <reference>
    <citation>Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013 Nov 21;369(21):1991-2000. doi: 10.1056/NEJMoa1306357.</citation>
    <PMID>24256378</PMID>
  </reference>
  <reference>
    <citation>Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008 Sep;93(9):3381-8. doi: 10.1210/jc.2007-2702. Epub 2008 Jul 1.</citation>
    <PMID>18593774</PMID>
  </reference>
  <reference>
    <citation>Diez-Juan A, Rubio C, Marin C, Martinez S, Al-Asmar N, Riboldi M, Díaz-Gimeno P, Valbuena D, Simón C. Mitochondrial DNA content as a viability score in human euploid embryos: less is better. Fertil Steril. 2015 Sep;104(3):534-41.e1. doi: 10.1016/j.fertnstert.2015.05.022. Epub 2015 Jun 11.</citation>
    <PMID>26051102</PMID>
  </reference>
  <reference>
    <citation>Seli E. Mitochondrial DNA as a biomarker for in-vitro fertilization outcome. Curr Opin Obstet Gynecol. 2016 Jun;28(3):158-63. doi: 10.1097/GCO.0000000000000274. Review.</citation>
    <PMID>27077472</PMID>
  </reference>
  <reference>
    <citation>Fragouli E, Spath K, Alfarawati S, Kaper F, Craig A, Michel CE, Kokocinski F, Cohen J, Munne S, Wells D. Altered levels of mitochondrial DNA are associated with female age, aneuploidy, and provide an independent measure of embryonic implantation potential. PLoS Genet. 2015 Jun 3;11(6):e1005241. doi: 10.1371/journal.pgen.1005241. eCollection 2015 Jun.</citation>
    <PMID>26039092</PMID>
  </reference>
  <reference>
    <citation>Blomberg Jensen M. Vitamin D and male reproduction. Nat Rev Endocrinol. 2014 Mar;10(3):175-86. doi: 10.1038/nrendo.2013.262. Epub 2014 Jan 14. Review.</citation>
    <PMID>24419359</PMID>
  </reference>
  <reference>
    <citation>Saadi HF, Nagelkerke N, Benedict S, Qazaq HS, Zilahi E, Mohamadiyeh MK, Al-Suhaili AI. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone. 2006 Nov;39(5):1136-1143. doi: 10.1016/j.bone.2006.05.010. Epub 2006 Jun 30.</citation>
    <PMID>16814623</PMID>
  </reference>
  <reference>
    <citation>Aleyasin A, Hosseini MA, Mahdavi A, Safdarian L, Fallahi P, Mohajeri MR, Abbasi M, Esfahani F. Predictive value of the level of vitamin D in follicular fluid on the outcome of assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):132-7. doi: 10.1016/j.ejogrb.2011.07.006. Epub 2011 Aug 10.</citation>
    <PMID>21835540</PMID>
  </reference>
  <reference>
    <citation>Yousefzadeh P, Shapses SA, Wang X. Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions. Int J Endocrinol. 2014;2014:981581. doi: 10.1155/2014/981581. Epub 2014 Apr 28. Review.</citation>
    <PMID>24868205</PMID>
  </reference>
  <reference>
    <citation>Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, Tournaye H, Tarlatzis B. New algorithm for OHSS prevention. Reprod Biol Endocrinol. 2011 Nov 3;9:147. doi: 10.1186/1477-7827-9-147.</citation>
    <PMID>22054506</PMID>
  </reference>
  <reference>
    <citation>La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014 Jan-Feb;20(1):124-40. doi: 10.1093/humupd/dmt037. Epub 2013 Sep 29. Review.</citation>
    <PMID>24077980</PMID>
  </reference>
  <reference>
    <citation>Van Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, Wisanto A, Devroey P. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 1993 Jul;8(7):1061-6.</citation>
    <PMID>8408487</PMID>
  </reference>
  <reference>
    <citation>Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, Camus M, Van Steirteghem A, Silber S. Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. Hum Reprod. 1995 Jun;10(6):1457-60.</citation>
    <PMID>7593514</PMID>
  </reference>
  <reference>
    <citation>Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P, Van Steirteghem A. Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. Fertil Steril. 2005 May;83(5):1397-403.</citation>
    <PMID>15866575</PMID>
  </reference>
  <reference>
    <citation>Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 2004 Dec;19(12):2849-58. Epub 2004 Oct 7.</citation>
    <PMID>15471934</PMID>
  </reference>
  <reference>
    <citation>Scott RT, Hofmann GE, Muasher SJ, Acosta AA, Kreiner DK, Rosenwaks Z. Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal follicular aspiration. J In Vitro Fert Embryo Transf. 1989 Apr;6(2):73-5.</citation>
    <PMID>2723509</PMID>
  </reference>
  <reference>
    <citation>Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod. 2000 Dec;15(12):2634-43.</citation>
    <PMID>11098037</PMID>
  </reference>
  <reference>
    <citation>Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72.</citation>
    <PMID>10523012</PMID>
  </reference>
  <reference>
    <citation>Meseguer M, Herrero J, Tejera A, Hilligsøe KM, Ramsing NB, Remohí J. The use of morphokinetics as a predictor of embryo implantation. Hum Reprod. 2011 Oct;26(10):2658-71. doi: 10.1093/humrep/der256. Epub 2011 Aug 9.</citation>
    <PMID>21828117</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2017</study_first_submitted>
  <study_first_submitted_qc>March 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2017</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IVI Middle East Fertility Clinic</investigator_affiliation>
    <investigator_full_name>Prof Dr. Human Fatemi</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

